After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

9th World One Health Congress in Lisbon

Last week we participated in the 9th World One Health Congress (9WOHC) in Lisbon, Portugal – a major global gathering dedicated to integrated human, animal, and environmental health approaches. Our

Read More

R-Evolution Sierra Leone

R-Evolution Worldwide Sierra Leone is a Local Voluntary Organization of Sierra Leoneans established to help and support vulnerable children, youth, women and communities to build a brighter future in changing

Read More

ITAIL-COVID-19 Project second press release

Summarising the latest most important achievements, the project ITAIL-COVID-19 (Integrated Testing Approaches and Intensive Laboratory training as strategy against COVID-19) second press release is now available: click here to download.

Read More